Description
An allosteric potentiator of nAChRs and inhibitor of acetylcholinesterase (IC50 = 636-2,010 nM); promotes acetylcholine activity in the brain and used in the clinical treatment of vascular dementia, Alzheimer’s disease, and other cognitive impairments
Formal name: (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol
Synonyms: NSC 100058
Molecular weight: 287.4
CAS: 357-70-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Drugs of Abuse||Research Area|Forensic Chemistry & Toxicology|Nootropics